• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为免疫治疗的前奏,采用在线亲和色谱法去除实验性重症肌无力兔体内的特异性抗体。

In-line affinity chromatographic removal of specific antibody from rabbits with experimental myasthenia gravis as a prelude to immunotherapy.

作者信息

Hinman C L, Stevens-Truss R

机构信息

Department of Medicinal & Biological Chemistry, University of Toledo, Ohio 43606, USA.

出版信息

Immunopharmacol Immunotoxicol. 1998 May;20(2):233-49. doi: 10.3109/08923979809038542.

DOI:10.3109/08923979809038542
PMID:9653670
Abstract

Myasthenia gravis is an autoimmune disease in which antibodies are produced against one's acetylcholine receptors, resulting in complement-mediated membrane destruction and internalization of antibody-receptor complexes. Symptoms range from weakening of extraocular muscles to severe impairment of movement and breathing. Prior to administering a therapeutic agent to eliminate antibody-producing lymphocytes, it will be necessary to remove specific antibody from the circulation. This process was investigated in an animal model of ex vivo specific immunoadsorption using awake, conscious rabbits. Following arterial blood separation, plasma was pumped upward through an affinity column containing covalently-bound acetylcholine receptor. Treated plasma was returned to the rabbit. Within a one-hour ex vivo procedure, specific antibody levels could be lowered from 16.2 ng/ml to less than 0.6 ng/ml, a reduction of more than 95%. By washing the column, at least four exchanges could be performed before specific antibody removal significantly diminished. The effects of specific antibody removal upon muscle function varied among individual rabbits, but if symptoms were not severe following passive transfer of purified monoclonal antibody to induce myasthenia, removal of 60% of the total specific antibody resulted in clinical improvement, as monitored by an animal's response to gallamine triethiodide.

摘要

重症肌无力是一种自身免疫性疾病,在该疾病中会产生针对自身乙酰胆碱受体的抗体,导致补体介导的膜破坏以及抗体 - 受体复合物的内化。症状范围从眼外肌无力到严重的运动和呼吸功能损害。在施用治疗剂以消除产生抗体的淋巴细胞之前,有必要从循环中去除特异性抗体。在使用清醒、有意识的兔子的离体特异性免疫吸附动物模型中对该过程进行了研究。分离动脉血后,血浆向上泵入含有共价结合的乙酰胆碱受体的亲和柱。处理后的血浆返回兔子体内。在一小时的离体过程中,特异性抗体水平可从16.2 ng/ml降至低于0.6 ng/ml,降低幅度超过95%。通过洗涤柱子,在特异性抗体去除显著减少之前可进行至少四次交换。特异性抗体去除对肌肉功能的影响在个体兔子之间有所不同,但如果在被动转移纯化的单克隆抗体以诱导重症肌无力后症状不严重,去除60%的总特异性抗体可导致临床改善,这通过动物对三碘季铵酚的反应来监测。

相似文献

1
In-line affinity chromatographic removal of specific antibody from rabbits with experimental myasthenia gravis as a prelude to immunotherapy.作为免疫治疗的前奏,采用在线亲和色谱法去除实验性重症肌无力兔体内的特异性抗体。
Immunopharmacol Immunotoxicol. 1998 May;20(2):233-49. doi: 10.3109/08923979809038542.
2
Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.对来自实验性自身免疫性重症肌无力敏感的Lewis大鼠和实验性自身免疫性重症肌无力抗性的Wistar Furth大鼠的抗乙酰胆碱受体抗体进行克隆型分析。
J Immunol. 1991 Jan 15;146(2):663-70.
3
Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.实验性重症肌无力兔中乙酰胆碱受体抗体的特异性
Clin Exp Immunol. 1980 Jul;41(1):13-8.
4
[Clinical correlation of anti-receptor antibody titer, sensitivity to curare and electromyographic changes in experimental autoimmune myasthenia gravis].[实验性自身免疫性重症肌无力中抗受体抗体滴度、对箭毒的敏感性与肌电图变化的临床相关性]
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1990 Oct;23(5):293-6, 320.
5
Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.乙酰胆碱受体抗体在人类及实验性重症肌无力诊断中的应用
Muscle Nerve. 1978 Sep-Oct;1(5):427-31. doi: 10.1002/mus.880010518.
6
Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis.重症肌无力患者血清中抗乙酰胆碱受体抗体的抗原特异性免疫吸附
Artif Cells Blood Substit Immobil Biotechnol. 2010 Apr;38(2):99-102. doi: 10.3109/10731191003634778.
7
[Long-term treatment of refractory myasthenia gravis with immunoadsorption].[免疫吸附法长期治疗难治性重症肌无力]
Dtsch Med Wochenschr. 2008 Nov;133(46):2377-82. doi: 10.1055/s-0028-1100928. Epub 2008 Nov 4.
8
Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.实验性重症肌无力受受体 - 抗受体复合物抑制。
J Clin Lab Immunol. 1982 Apr;7(3):223-7.
9
Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.人重症肌无力中抗烟碱型乙酰胆碱受体抗体的酶联免疫吸附测定
Ann Neurol. 1984 Feb;15(2):195-200. doi: 10.1002/ana.410150214.
10
Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using antigen-ricin A chain immunotoxin.利用抗原-蓖麻毒素A链免疫毒素对纯化的乙酰胆碱受体的抗体反应进行体外选择性抑制。
J Immunol. 1985 Nov;135(5):3062-7.